AIDAR
LIVE

Serial Number

88514109

Owner

Multisensor Diagnostics, LLC

Attorney

Andy I. Corea

First Use Date

May 31, 2019

Filing Date

Jul 15, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AIDAR Trademark

Serial Number: 88514109 • Registration: 6262613

AIDAR is a trademark filed by Multisensor Diagnostics, LLC on July 15, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Multisensor Diagnostics, LLC (5 trademarks)

3402 Birch Hollow Rd
Pikesville, MD 21208

Entity Type: 16

Trademark Details

Filing Date

July 15, 2019

Registration Date

February 2, 2021

First Use Anywhere

May 31, 2019

First Use in Commerce

July 3, 2019

Published for Opposition

March 3, 2020

Goods & Services

Health care services, namely, providing a database in the field of disease detection, therapy and management information for treatment and diagnostic purposes; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Health care services, namely, behavioral therapy for an individual or group of individuals for medical diagnosis, management, and treatment purposes; Providing wellness and disease management programs; behavioral health counseling services, namely, programs in the field of behavioral change to promote wellness and disease management; mental health care counseling services; personal health assessments, namely, personal assessments of health risk, fitness, nutrition and lifestyle; providing smoking cessation and weight loss program services; managed health care services, including, health and wellness counseling services; disease care management services; nursing services; medical care home care services, namely, providing personalized and customized health and wellness assessment, health care, disease management, medical treatment and wellness plans and programs; medical care services, namely, providing personalized and customized advice and recommendations on home health treatment and care programs, providing assistance in transitioning patients from hospital to home, and evaluating and monitoring a patient's condition; providing on-line health care and health information relating to health coaching services; Medical evaluation services, namely, assessment of patients undergoing medical treatment; medical diagnostic monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; maintaining patient medical records and files; medical counseling; medical screening; medical testing for diagnostic or treatment purposes; Dietitian services; Nutrition counseling; Dietary and nutritional guidance; Disease management as a service (DMaaS) services, namely, providing medical analytics and healthcare services all for use by others for use for disease progression prediction and for medical status assessment

Business consulting and management in the field of clinical care, clinical research and clinical trials, namely, clinical data and regulatory submission management on behalf of medical, data analytics, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data and patient reported subjective and objective data for business purposes; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Services consisting of the registration, collection, transcription, compilation and systemization of written communications and data; Health care cost containment services; health care utilization management and review services; medical cost management

Disease management as a service (DMaaS) services, namely, providing a website featuring technology for use by others to analyze disease progression prediction and for medical status assessment; Software as a service (SaaS) services, namely, hosting and managing software for use by others for use for overall health assessment; Data as a service (DaaS) services featuring software for use to determine effective drugs, therapies and medications; Behavior Change as a service (BCaaS) services in the nature of software as a service (Saas) featuring software for facilitating behavior science backed coaching and training for use by others for behavior modification and healthy lifestyle modification; Platform as a service (PaaS) featuring computer software platforms for the collection, processing, storage and exchange of human health and disease data; Platform as a service (PaaS) featuring computer software platforms to derive insights and understanding about human health and disease; Platform as a service (PaaS) featuring computer software platforms for predictive analytics; Platform as a service (PAAS) featuring computer software platforms for disease progression prediction; Platform as a service (PAAS) featuring computer software platforms for medical status assessment and making medical decisions; Platform as a service (PaaS) featuring computer software platforms for determining effective therapies and medications; Platform as a service (PaaS) featuring computer software platforms for providing behavior therapy; providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research services in the fields of blood, breath, and saliva analysis and health care monitoring; breath and saliva biochemical analysis services; biological research; biomedical research; laboratory research in the field of biochemistry, biology, health and medicine; providing a web site featuring on-line non-downloadable software that enables patients, physicians, insurers, biopharmaceuticals and other healthcare providers to generate, evaluate, manage and exchange medical information; Providing temporary use of on-line non-downloadable software and applications for communications between patients, payers, biopharmaceuticals, caregivers, contract research organizations, and health care providers in conducting health assessments, health coaching, preventative health measures, condition management, and making informed health decisions; Providing temporary use of on-line non-downloadable software for collecting patient and care giver health information and facilitating communications between patients, payers, biopharmaceuticals, caregivers, contract research organizations, and health care providers, and predicting, recording, reporting, transmitting, tracking and monitoring patient real-time vital health information

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 2, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 2, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 31, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 30, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 13, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 12, 2020 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2020 EXRA
USE AMENDMENT FILED
Oct 28, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 28, 2020 EISU
SOU EXTENSION 1 GRANTED
Oct 28, 2020 EX1G
SOU EXTENSION 1 FILED
Oct 28, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 28, 2020 EEXT
ASSIGNED TO EXAMINER
Jul 27, 2020 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 29, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 29, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 29, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 29, 2020 CNEA
EXAMINER'S AMENDMENT ENTERED
Jan 28, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 28, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 28, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 28, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 21, 2020 GNFN
FINAL REFUSAL E-MAILED
Jan 21, 2020 GNFR
FINAL REFUSAL WRITTEN
Jan 21, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 1, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2019 NWOS
NEW APPLICATION ENTERED
Jul 18, 2019 NWAP